Onco-Innovations Appoints Jared Rushton to Board of Directors
Onco-Innovations (OTCQB:ONNVF) appointed Jared Rushton to its Board of Directors, effective October 30, 2025, replacing Zachary Stadnyk.
Mr. Rushton brings over a decade of public markets experience in corporate development, strategic advisory and capital markets planning across mining, cannabis and biotech sectors.
The company also engaged MCS Market Communication Service GmbH for online marketing services through December 15, 2025 (or until budget exhaustion) and paid EUR 600,000 in consideration; no securities were issued to MCS. Services include Google Ads, native advertising, campaign creation, and analytics.
Onco-Innovations (OTCQB:ONNVF) ha nominato Jared Rushton al suo Consiglio di Amministrazione, con effetto dal 30 ottobre 2025, in sostituzione di Zachary Stadnyk.
Il signor Rushton vanta oltre un decennio di esperienza nei mercati pubblici in sviluppo corporate, consulenza strategica e pianificazione dei mercati dei capitali nei settori minerario, cannabis e biotech.
La società ha inoltre incaricato MCS Market Communication Service GmbH per servizi di marketing online fino al 15 dicembre 2025 (oppure fino all'esaurimento del budget) e ha pagato EUR 600.000 in contropartita; nessun titolo è stato emesso a favore di MCS. I servizi includono Google Ads, pubblicità native, creazione di campagne e analisi.
Onco-Innovations (OTCQB:ONNVF) designó Jared Rushton a su Junta Directiva, con efecto a partir del 30 de octubre de 2025, sustituyendo a Zachary Stadnyk.
El señor Rushton aporta más de una década de experiencia en mercados públicos en desarrollo corporativo, asesoría estratégica y planificación de mercados de capitales en los sectores minero, cannabis y biotecnológico.
La empresa también contrató MCS Market Communication Service GmbH para servicios de marketing en línea hasta el 15 de diciembre de 2025 (o hasta agotar el presupuesto) y pagó EUR 600,000 como contraprestación; no se emitieron valores a MCS. Los servicios incluyen Google Ads, publicidad nativa, creación de campañas y análisis.
Onco-Innovations (OTCQB:ONNVF)가 이사회에 Jared Rushton을 임명했고, 2025년 10월 30일부로 발효되며 Zachary Stadnyk를 대체합니다.
루션은 광산, 대마초 및 생명공학 부문에서 기업 개발, 전략 자문 및 자본시장의 계획에 걸쳐 10년이 넘는 공적 시장 경험을 보유하고 있습니다.
회사는 또한 MCS Market Communication Service GmbH를 온라인 마케팅 서비스용으로 2025년 12월 15일까지(또는 예산 소진 시까지) 계약했고, EUR 600,000를 대가로 지급했습니다; MCS에 증권이 발행되지 않았습니다. 서비스에는 Google Ads, 네이티브 광고, 캠페인 생성 및 분석이 포함됩니다.
Onco-Innovations (OTCQB:ONNVF) a nommé Jared Rushton à son conseil d'administration, à compter du 30 octobre 2025, en remplacement de Zachary Stadnyk.
M. Rushton apporte plus d'une décennie d'expérience sur les marchés publics dans le développement d'entreprise, les conseils stratégiques et la planification des marchés de capitaux dans les secteurs minier, du cannabis et de la biotechnologie.
La société a également mandaté MCS Market Communication Service GmbH pour des services de marketing en ligne jusqu'au 15 décembre 2025 (ou jusqu'à épuisement du budget) et a payé EUR 600 000 en contrepartie; aucun titre n'a été émis à MCS. Les services comprennent Google Ads, publicité native, création de campagnes et analyses.
Onco-Innovations (OTCQB:ONNVF) ernannte Jared Rushton in den Vorstand, wirksam ab dem 30. Oktober 2025, und ersetzt damit Zachary Stadnyk.
Herr Rushton bringt über ein Jahrzehnt Erfahrung an öffentlichen Märkten in Unternehmensentwicklung, strategischer Beratung und Planung der Kapitalmärkte in den Sektoren Bergbau, Cannabis und Biotechnologie mit.
Das Unternehmen beauftragte außerdem MCS Market Communication Service GmbH für Online-Marketing-Dienstleistungen bis zum 15. Dezember 2025 (oder bis zum Budget depletion) und zahlte EUR 600.000 als Gegenleistung; keine Wertpapiere wurden an MCS ausgegeben. Zu den Dienstleistungen gehören Google Ads, Native Advertising, Kampagnen-Erstellung und Analytics.
Onco-Innovations (OTCQB:ONNVF) عيّنت Jared Rushton عضواً في مجلس إدارتها، اعتباراً من 30 أكتوبر 2025، بدلاً من Zachary Stadnyk.
يجلب السيد روستون أكثر من عقد من الخبرة في الأسواق العامة في التطوير المؤسسي، والاستشارات الإستراتيجية وتخطيط أسواق رأس المال عبر قطاعات التعدين والقنب الصناعي والتكنولوجيا الحيوية.
كما تعاقدت الشركة أيضاً مع MCS Market Communication Service GmbH لخدمات التسويق عبر الإنترنت حتى 15 ديسمبر 2025 (أو حتى نفاد ميزانية) ودفعت EUR 600,000 كتسوية؛ لم تُصدر أية أوراق مالية لـ MCS. تشمل الخدمات Google Ads، الإعلان الأصلي، إنشاء الحملات والتحليلات.
- Board appointment of Jared Rushton effective 2025-10-30
- Rushton brings 10+ years public markets and capital markets experience
- MCS engagement secures digital marketing through 2025-12-15
- EUR 600,000 cash paid upfront to MCS for services
- Board turnover: director Zachary Stadnyk stepped down
VANCOUVER, BC / ACCESS Newswire / October 30, 2025 / Onco-Innovations Limited (CBOE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company"),is pleased to announce the appointment of Mr. Jared Rushton to its Board of Directors, effective immediately. Mr. Rushton brings over a decade of experience in the public markets, with a strong background in corporate development, strategic advisory, and capital markets planning. Throughout his career, he has worked closely with emerging and growth-stage companies to support financing initiatives, investor engagement, market positioning, and operational execution.
His diverse industry experience spans the mining, cannabis, and biotech and health sciences sectors, where he has played a key role in evaluating strategic opportunities, structuring partnerships, and guiding long-term growth strategies. Mr. Rushton has also advised on go-public transactions, corporate restructuring, and business development programs designed to enhance corporate value and strengthen shareholder alignment.
Mr. Rushton replaces Mr. Zachary Stadnyk, who has stepped down from the Board. The Company extends its gratitude to Mr. Stadnyk for his dedication and contributions during his tenure.
The Company also announces the engagement of MCS Market Communication Service GmbH (business address: Saarlandstraße 28 58511 Lüdenscheid, Germany, email: info@mcsmarket.de; telephone: +491772481220; and website: www.mcsmarket.de) ("MCS") for the provision of a range of online marketing services, including campaign creation, production of marketing materials, as well as research and analytics (the "Services"). The Services are expected to run until December 15, 2025 or budget exhaustion. The Company has paid MCS EUR 600,000 as consideration for its services. No securities have been provided to MCS or its principals as compensation for the Services. The Services will be executed via digital channels, including Google Ads and native advertising.
About Onco-Innovations Limited
Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide license to patented technology that targets solid tumours.
ON BEHALF OF ONCO-INNOVATIONS LIMITED,
"Thomas O'Shaughnessy"
Chief Executive Officer
For more information, please contact:
Thomas O'Shaughnessy
Chief Executive Officer
Tel: + 1 888 261 8055
investors@oncoinnovations.com
Forward-Looking Statements Caution. This news release contains forward-looking statements, including in relation to the prospects of the Company, and the Company's business and plans generally, and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "potential", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
SOURCE: Onco-Innovations Limited
View the original press release on ACCESS Newswire
FAQ
Who was appointed to the Onco-Innovations board on October 30, 2025 (ONNVF)?
Who did Jared Rushton replace on the Onco-Innovations board (ONNVF)?
How much did Onco-Innovations pay MCS for marketing services and until when will services run (ONNVF)?
Did Onco-Innovations issue any securities to MCS as part of the marketing engagement (ONNVF)?
What digital channels will MCS use for Onco-Innovations marketing (ONNVF)?
